[1]Dai Y L, Xu C, Sun X L, et al. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment[J]. Chem Soc Rev, 2017, 46(12): 3830-3852.
[2]Sung H, Ferlay J, Siegel R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[3]Qin S Y, Cheng Y J, Lei Q, et al. Combinational strategy for high-performance cancer chemotherapy[J]. Biomaterials, 2018, 171: 178-197.
[4]Shi J J, Kantoff P W, Wooster R, et al. Cancer nanomedicine: progress, challenges and opportunities[J]. Nat Rev Cancer, 2017, 17(1): 20-37.
[5]Goldspiel B R. Pharmaceutical issues: preparation, administration, stability, and compatibility with other medications[J]. Ann Pharmacother, 1994, 28(5 Suppl): S23-S26.
[6]Gabizon A, Catane R, Uziely B, et al. Prolonged circula-tion time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes[J]. Cancer Res, 1994, 54(4): 987-992.
[7]Schroeder A, Kost J, Barenholz Y. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes[J]. Chem Phys Lipids, 2009, 162(1/2): 1-16.
[8]Baghban R, Roshangar L, Jahanban-Esfahlan R, et al. Tumor microenvironment complexity and therapeutic implications at a glance[J]. Cell Commun Signal, 2020, 18(1): 59.
[9]Zhou W X, Jia Y J, Liu Y N, et al. Tumor microenvironment-based stimuli-responsive nanoparticles for controlled release of drugs in cancer therapy[J]. Pharmaceutics, 2022, 14(11): 2346.
[10]Zhao R Y, Fu C X, Wang Z H, et al. A pH-responsive nanoparticle library with precise pH tunability by co-polymerization with non-ionizable monomers[J]. Angew Chem Int Ed Engl, 2022, 61(19): e202200152.
[11]Yin Q Q, Pan A N, Chen B L, et al. Quantitative imaging of intracellular nanoparticle exposure enables prediction of nanotherapeutic efficacy[J]. Nat Commun, 2021, 12(1): 2385.
[12]Zhao J Y, Yang Y, Han X, et al. Redox-sensitive nanoscale coordination polymers for drug delivery and cancer theranostics[J]. ACS Appl Mater Interfaces, 2017, 9(28): 23555-23563.
[13]Chai Z D, Teng C, Yang L, et al. Doxorubicin delivered by redox-responsive hyaluronic acid-ibuprofen prodrug micelles for treatment of metastatic breast cancer[J]. Carbohydr Polym, 2020, 245: 116527.
[14]He X, Zhang J X, Li C, et al. Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy[J]. Theranostics, 2018, 8(18): 4884-4897.
[15]Lin L S, Song J B, Song L, et al. Simultaneous fenton-like ion delivery and glutathione depletion by MnO2 -based nanoagent to enhance chemodynamic therapy[J]. Angew Chem Int Ed Engl, 2018, 57(18): 4902-4906.
[16]Peng S J, Xiao F F, Chen M W, et al. Tumor-microenvironment-responsive nanomedicine for enhanced cancer immunotherapy[J]. Adv Sci, 2022, 9(1): e2103836.
|